Focal Spot, Spring 2001 by unknown
Washington University School of Medicine
Digital Commons@Becker
Focal Spot Archives Focal Spot
Spring 2001
Focal Spot, Spring 2001
Follow this and additional works at: http://digitalcommons.wustl.edu/focal_spot_archives
This Book is brought to you for free and open access by the Focal Spot at Digital Commons@Becker. It has been accepted for inclusion in Focal Spot
Archives by an authorized administrator of Digital Commons@Becker. For more information, please contact engeszer@wustl.edu.
Recommended Citation
Focal Spot, Spring 2001, April 2001. Bernard Becker Medical Library Archives. Washington University School of Medicine.







T*   V* 
Launching an Image Study of 






VOLUME 32, NUMBER 1 
THE PEREZ SYMPOSIUM 
Carlos Perez has made significant and lasting contributions to the field of 
radiation oncology. The symposium "Current Topics in Cancer Treatment" 
honors Dr. Perez for his clinical, academic, and research expertise. 
WHEN BREAST CANCER 
BECOMES PART OF A WOMAN'S LIFE 
An educational booklet and video produced by breast 
cancer specialists at Washington University Medical 
Center provides newly diagnosed breast cancer 
patients with a straightforward, supportive approach 
for addressing concerns about their disease. 
LAUNCHING AN IMAGE STUDY OF 
POLYCYSTIC KIDNEY DISEASE 
After nearly a year in planning and development, 
a multi-institutional study is evaluating the 
accuracy of magnetic resonance imaging in 
determining the progression of the most common 
genetic kidney disorder—autosomal-dominant 
polycystic kidney disease. 
IMRT UPDATE 
Armed with state-of-the art imaging equipment 
and the best available computer planning system, 
radiation oncologists are using a novel 
radiation treatment called intensity modulated 
radiation therapy to effectively treat head and 
neck cancers while reducing significant side 
effects, including xerostomia (dry mouth). 
ON THE COVER: Ty Bae, MD, PhD, draws upon his expertise in body 
imaging, as well as image analysis, quantification, and processing, as 
he leads a National Institutes of Health study that eventually may affect 
more than 600,000 people in the United States who have polycystic kid- 







Perry Grigsby, MD, MBA, 
professor of radiology, was 
selected as the 2000 Radia- 
tion Oncology Teacher of the 
Year, making him a three- 
time recipient of the award 
(including 1991 and 1995). 
The radiation oncology resi- 
dents select the award recipi- 
ent by nominating and voting 
for the MIR faculty member 
who makes a significant con- 
tribution to radiation oncol- 
ogy resident education 
during the academic year. 
During the presentation 
of the award—traditionally 
given each year in Decem- 
ber— Imran Zoberi, MD, radi- 
ation oncology chief 
resident 2000-2001, said 
"Doctor Grigsby's teaching 
abilities are known nation- 
ally, which is evident by the 
number of out-of-state resi- 
dents who come to the 
Radiation Oncology Center 
just to rotate through his 
[Grigsby'sj gynecology 
service." 
Grigsby joined the MIR 
faculty in 1986 as an assistant 
professor of radiology, after 
completing four years of 
training in radiation oncology 
(chief resident 1985-1986) at 
Mallinckrodt Institute. He has 
served as chief of the Radia- 
tion Oncology Center's gyne- 
cology service since 1987. As 
changes in the healthcare 
environment began to dra- 
matically affect patient care, 
Grigsby joined the growing 
trend of physicians earning 
business degrees and 
received an MBA in 1990 
from Olin School of Business 
at Washington University in 
St. Louis. 
Grigsby is regularly 
listed among the nation's 
medical experts in refer- 
ences such as The Best 
Doctors in America, Who's 
Who in Medicine and 
Healthcare, and Guide to 
Top Doctors. He has 
authored and coauthored 
more than 180 scientific arti- 
cles and book chapters and 
has served in editorial posi- 
tions for several scientific 
journals, including The 
International Journal of 
Radiation Oncology, Biol- 
ogy, and Physics. 
Grigsby has served 
since 1993 as chairman of 
the Radiation Therapy 
Oncology Group's Economic 
Impact Committee, chaired 
the American Society of 
Therapeutic Radiation 
Oncology's Long Range Plan- 
ning Committee from 1988 to 
1996, and was appointed in 
2000 to the Gynecologic 
Task Force of the American 
Joint Committee on Cancer. 
He is a member of several 
medical organizations, 
including the American Soci- 
ety of Clinical Oncology and 
the American Brachytherapy 
Society, and is a fellow of 
the American College of 
Radiology. 
Since the award's 
inception in 1989, the 
following faculty have been 
selected as teacher of 
the year: 
• 1989—Susan Shapiro, MD 
• 1990—Carlos Perez, MD 
• 1991, 1995, 2000—Perry 
Gi-igsby, MD, MBA 
• 1992—Jeff Michalski, MD 
• 1993—Russell Gerber, MS 
• 1994—Mary Graham, ML 
• 7996—James Purdy, PhD 
• 1997—Marie Taylor, MD 
• 1998—David Gius, MD, Phi' 
• 1999-^Jeffrey Bradley, Ml 
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In recognition for his dis- 
inguished accomplishments 
n service and teaching, 
jawrence Kotner, MD, associ- 
ite professor of radiology, 
NZS elected a fellow of the 
American College of Radiol- 
ogy (ACR). The induction 
ceremony will be held in 
September during the ACR's 
78th Annual Meeting in San 
Francisco. 
The ACR, comprised of 
more than 30,000 radiologists, 
n—radiation oncologists, and 
medical physicists, supports 
programs focusing on the 
practice of radiology and the 
delivery of comprehensive 
radiological health services, 
'ellowship is one of the 
\CR's highest honors given to 
ts members. 
Kotner joined the MIR 
acuity in 1975 and has served 
as course master for the 
Senior Medical Student Radi- 
ology Elective since 1988. He 
was director of the Radiology 
Residency Program at Jewish 
Hospital from 1989 to 1994, 
when the program merged 
with Barnes Hospital's train- 
ing program. He now serves 
as associate director of 
Vlallinckrodt Institute's four- 
year diagnostic radiology 
training program, the largest 
of its kind in the United 
States. 
In 1989 and in 1991, he 
received Washington Univer- 
ity's Sydney S. Pearl MD '32 
Award for Inspirational 
Teaching. In recognition of 
|tis leadership quality and 
pmportant contributions to 
pedical student and radiol- 
ogy resident education, Kot- 
ner was elected in 1998 as an 
alumni member of the Wash- 
ington University Chapter of 





Carlos Perez, MD, pro- 
fessor of radiology and 
director of the Radiation 
Oncology Center, received 
The National Children's Can- 
cer Society Legacy Award 
2001 for his "significant and 
lasting contributions in the 
fight against cancer" and for 
his "exceptional and distin- 
guished leadership in the 
field of radiology." The 
award was presented in 
March at the Society's Inter- 
national Humanitarian 
Award Dinner 2001. 
Founded in 1987, The 
National Children's Cancer 
Society is a not-for-profit 
organization that provides 
direct financial assistance to 
children with cancer and to 
their families. Headquar- 
tered in St. Louis, the Soci- 
ety was founded on the 
belief that no child with can- 
cer should be denied access 
to quality medical care 
because of a lack of funds. 
Perez's career spans 
four decades, and during 
those years he has become 
one of the most highly 
regarded radiation oncolo- 
gists in the world, particu- 
larly in the management of 
patients with gynecologic 
tumors and carcinoma of the 
prostate and of the breast. 
Perez tends not only to the 
physical needs of patients 
but also to their emotional 
and psychological needs. He 
has received numerous 
recognitions, including the 
American College of Radiol- 
ogy's Gold Medal Award and 
the American Society for 
Therapeutic Radiology and 
Oncology's Gold Medal. 
Perez joined the MIR 
faculty in 1964 and was 
named director of the Radia- 
tion Oncology Center in 
1976. Under his leadership, 
the Radiation Oncology Cen- 
ter is a premier radiation 
treatment center with a 
strong research core. In 1977 
Perez established the Cancer 
Information Center (CIC) for 
patients and their families 
and friends, as well as for 
physicians. The CIC was the 
first resource facility of its 
kind worldwide and has 
served as a model for similar 
centers in the United States 
and abroad. 
WUSM among 
top five in U.S. 
Washington University 
School of Medicine (WUSM) 
was named one of the top five 
medical schools for research 
in the United States, accord- 
ing to the U. S. News & World 
Report 2001 annual rankings 
of best graduate schools. 
WUSM ranked fourth (tied 
with University of Pennsylva- 
nia), following Harvard, Johns 
Hopkins, and Duke. 
Now in its fifteenth 
year, U. S. News & World 
Report rankings are based 
on varying criteria, including 
a school's reputation, 
research activity, student 






As part of the Matching 
Program, 17 physicians are 
slated to join MIR's Diagnos- 
tic Radiology Residency 
Program; one of the 17 will 
participate in the Research 
Residency Program. These 
promising young trainees 
represent excellent medical 
schools: Yale University, 
Johns Hopkins University, 
University of California at 
San Francisco, Saint Louis 
University, Medical College 
of Virginia, Texas Tech Uni- 
versity, University of South 
Florida, Northwestern Univer- 
sity, University of Wisconsin, 
Hahnemann University, Uni- 
versity of Alabama, University 
of North Carolina, University 
of Arizona, and Washington 
University in St. Louis. 
V'UCAL SPOT, SPRING 2001 







Mark Mintun, MD, profes- 
sor of radiology and of psychia- 
try, was appointed to a 
three-year term as a member of 
the Integrative, Functional and 
Cognitive Neuroscience Study 
Section of the Center for Scien- 
tific Review, sponsored by the 
National Institutes of Health 
(NIH). Founded in 1887, the 
NIH is one of the world's fore- 
most medical research centers. 
It is comprised of 25 separate 
institutes and centers that focus 
on acquiring knowledge to help 
prevent, detect, diagnose, and 
treat disease and disability. 
Center for Scientific 
Review members are selected 
on the basis of demonstrated 
competence and achievement 
in their scientific discipline, as 
evidenced by the quality of 
their research accomplish- 
ments and scientific publica- 
tions. Study sections 
contribute to the national bio- 
medical research effort by 
reviewing grant applications 
submitted to the NIH and then 
making recommendations to 
the appropriate NIH national 
advisory council or board. 
After completing a 
research fellowship in neurol- 
ogy at Washington University 
and a nuclear medicine resi- 
dency at Mallinckrodt Institute, 
Mintun joined the MIR faculty 
in 1985 as an assistant profes- 
sor of radiology. In 1989 his 
research took him to the Uni- 
versity of Michigan and then to 
the University of Pittsburgh. 
He returned to MIR in 1997 to 
continue his research using 
positron emission tomography 
to study the metabolic needs of 
the brain during the neural 
process and to investigate 
the biology of depression 
treatment. 
Welch dedicates Imaging Center 
In June of 1999, 
Yoshiharu Yonekura, MD, direc- 
tor of the High Energy Medical 
Research Center at Fukui 
Medical University, and 
Ronald Evens, MD, then direc- 
tor of the Institute, signed a 
five-year academic exchange 
and cooperation agreement 
(one copy in English, the 
other in Japanese) between 
the two institutions. Michael 
Welch, PhD, professor of radi- 
ology and of chemistry and 
codirector of the Division of 
Radiological 
Sciences, was instru- 
mental in coordinat- 





necessary for the joint 
research activities. 
Welch's long-time 
collaboration with the 
Japanese university on 
radiopharmaceutical research 
includes the development of 
an imaging agent for hypoxia 
that was used in clinical 
srr 
E2 jf~ij 
studies at Mallinckrodt 
Institute. He recently travelled | 
to Japan to participate in the 
dedication of the Biomedical 
Imaging Research Center at 
Fukui Medical University. 
Welch (third from right) and other Fukui University officials cut the ceremonial ribbon at the opening of the new imaging center. 
MALLINCKRODT INSTITUTE OF RADIOLOG I 
HE PEREZ SYMPOSIUM 
CURRENT TOPICS IN 
CANCER TREATMENT 
^Dr.  IPereZ is being hon- 
ored for his many contributions to 
the scientific knowledge of radia- 
tion oncology in the education of 
radiation oncologists, physicists, 
dosimetrists, nurses, and thera- 
pists, and for the highest quality 
clinical care he has provided for 
more than 40 years to thousands of 
patients. We hope you will attend 
this symposium in recognition of 
Dr. Perez. 
THERE IS NO CHARGE FOR THE 
SYMPOSIUM, LUNCH, OR RECEPTION. 
PRE-REGISTRATION IS ENCOURAGED 
TO GUARANTEE SEATING; HOWEVER, 
REGISTRATION AT THE DOOR WILL 
BE ACCEPTED. 
On honor of Carlos U^erez, uWD, 
professor of radiology and 
director of the Radiation Oncology Center. 
Jriday • £June I, 2001 
7-'^0 a.m. to S-'^O p.m. 
Sponsored by 
Washington University School of Medicine in St. Louis 
Mallinckrodt Institute of Radiology 
The Radiation Oncology Center 
[yield at 
The Eric P. Newman Education Center 
320 South Euclid Avenue (on the medical center campus) 
program 
7:30 a.m.—8:00 a.m. 
Registration and Continental Break- 
fast in the Newman Center Lobby 
8:00 a.m.—8:15 a.m. 
Welcome 
8:15 a.m.—8:45 a.m. 
Proton Radiation: The Ultimate in 
External Beam Therapy? 
Herman Suit, MD 
Chairman Emeritus 
Department of Radiation Oncology 
Harvard University 
8:45 a.m.—9:15 a.m. 
Cardiovascular Radiation: 
The New Frontier 
Philip Rubin, MD 
Chairman Emeritus 
Department of Radiation Oncology 
University of Rochester 
9:15 a.m.—9:45 a.m. 
Radiation Therapy for Benign 
and Not So Benign Disease 
Luther Brady, MD 
Professor and Chairman Emeritus 
Department of Radiation Oncology 
Hahnemann University 
iProcjram continued 
9:45 a.m.—10:15 a.m. 
Alpha/Beta Really Is Small for 
Prostate Tumors 
Jack Fowler, DSc, PhD 
Department of Human Oncology 




10:30 a.m.—11:00 a.m. 
MultidiscipUnary Therapy 
ofPediatric Cancer 
Teresa Vietti, MD 
Professor Emeritus 
Pediatric Oncology 
Washington University in St. Louis 
11:00 a.m.—11:30 a.m. 
Combined Modality Therapy 
at Cervical Center 
William Hoskins, MD 
Chief, Gynecologic Oncology 
Memorial-Sloan Kettering 
Cancer Center 
11:30 a.m.—12 noon 
Combined Modality Therapy for 
Head and Neck Cancer 
Bahman Emami, MD 
Professor and Chairman 
Department of Radiation Therapy 
Loyola University 
12 noon—12:30 p.m. 
Metastatic Bone Cancer 




12:30 p.m.—1:30 p.m. 
Box lunch provided at 
Newman Center 
1:30 p.m.—2:00 p.m. 
MultidiscipUnary Treatment of 
Breast Cancer- 
Bernard Fisher, MD 
Professor, Department of Surgery 
Allegheny University 
of the Health Sciences 
2:00 p.m.—2:30 p.m. 
Clinical Uses of 
Chemotherapy/Radiotherapy 
John Durant, MD 
past Executive Director of the 
American Society of Clinical Oncology 
2:30 p.m.—3:00 p.m. 
Benefits of Improved Accuracy in 
Radiation Treatment of Prostate 
Cancer 
Gerald Hanks, MD 
Chairman 
Department of Radiation Oncology 
Fox Chase Cancer Center 
3:00 p.m.—3:15 p.m. 
A Phase II Study of Gemcitabine  . 
Combined with Radiation Therapy 
in Patients with Localized Unre- 
sectable Pancreatic Cancer 
Avraham Kuten, MD 
Professor and Head 
Radiotherapy Unit 
Rambam Medical Center 
Haifa, Israel 
3:15 p.m.—3:30 p.m. 
New Directions in the Management 
of Rectal Cancer 
Vincenzo Valentini, MD 
Professor Department of Radiotherapy 
Catholic University 
Rome, Italy 
3:30 p.m.—3:50 p.m. 
Break 
3:50 p.m.—4:20 p.m. 
Cancer Centers in the 21st Century 
Robert Young, MD 
President 
Fox Chase Cancer Center 
^Registration 
4:20 p.m.—4:50 p.m. 
The Significant Contributions of 
Carlos A. Perez, MD 
James Cox, MD 
Chairman 
Department of Radiation Oncology 
M. D. Anderson Cancer Center 
4:50 p.m.—5:00 p.m. 
The New Radiation 
Oncology Center 
Todd Wasserman, MD 
Professor of Radiology 
Mallinckrodt Institute of Radiology 
at Washington University in St. Louis 
5:00 p.m.—5:30 p.m. 
Final Remarks 
5:30 p.m.—7:00 p.m. 
Reception 
New Radiation Oncology Center 
Alvin J. Siteman Cancer Center 
4921 Parkview Place, Lower Level 
THERE IS NO CHARGE FOR THE 
SYMPOSIUM, LUNCH, OR RECEP- 
TION. PRE-REGISTRATION IS 
ENCOURAGED TO GUARANTEE 
SEATING; HOWEVER, REGISTRATION 
AT THE DOOR WILL BE ACCEPTED. 
Please respond by May 22, 2001, 
by mailing this registration to 
Washington University School 
of Medicine, Office of Special 
Programs, Campus Box 8512, 
660 Euclid Avenue, St. Louis, 
MO 63110-9825. 
Or register by calling The 
Office of Special Programs 
at 314-286-0073. 
Please check the events you 
will be attending. 
□     Symposium 
 Number of persons 
attending 
Name(s)_ 
□     Lunch 
. Number of persons 
attending 
Name(s)_ 
□     Reception 
 Number of persons 
attending 
Name(s)_ 
when Breast Cancer 
Becomes Part of a 
Woman's Life 
Breast cancer specialists 
provide straightforward, 
supportive resources 
that address concerns 
accompanying a diagnosis 
of breast cancer. 
hen a woman is told she has 
breast cancer, it is often a 
terrifying time, causing her to 
rush to the library, the Internet, 
and other resources to become better informed and to calm 
her fears. The resources available do not always meet a 
woman's needs, though, as Deborah Price will agree. 
by Barbra Rodriguez 
Diagnosed with breast cancer 
in 1998, Price remembers the anx- 
ious moments spent in the waiting 
room of a local breast imaging cen- 
ter before her cancer diagnosis was 
confirmed. "What I remember see- 
ing when I was having a second 
mammogram was a videotape that 
was really impersonal and rather 
sad," Price says, adding that she 
had no one with her to help process 
that experience. 
Now thanks to women like 
Price, a team of physicians from 
Mallinckrodt Institute of Radiology, 
and the staff of the Barnes-Jewish 
Hospital Breast Health Center, a 
new booklet and companion video 
are available to provide a straight- 
forward, supportive approach for 
addressing concerns that arise 
when breast cancer becomes part 
of a woman's life. 
The factual booklet, "One Step 
at a Time," covers a host of topics 
in 10 brief chapters. The first five 
chapters focus on basic breast can- 
cer facts and myths, health team 
members, treatment types, and 
what to expect from breast recon- 
struction surgery. 
Chapters 6 through 8 address a 
woman's feelings after diagnosis, 
her legal and other rights, and what 
she can expect in follow-up care. 
To round out the booklet, a 
glossary and list of support groups 
are included, as well as a pocket on 
the back page for storing informa- 
tion. All of this, plus illustrations, 
comes in a span of 32 pages that 
can fit inside a woman's handbag. 
"We really wanted something that 
was useful and easy to read. Infor- 
mation that could be used in time 
of need, when the patient is too dis- 
traught to sit down and plough 
through a lengthy book," says 
Maria Schmidt, MD, assistant pro- 
fessor of radiology, who directed 
the project to produce the booklet 
and video. 
The 8-minute video, "Between 
Friends," delves into emotional 
issues, using breast cancer sur- 
vivors and medical specialists to 
convey six core messages. These 
include reminders that many 
women do survive breast cancer, 
they should not be afraid to ask 
questions, and they should be prac- 
tical in their expectations of them- 
selves during treatment. A positive 
attitude also is emphasized, as are 
the importance of developing a 
support team, celebrating life, and 
moving on after being diagnosed. 
The booklet and video are the 
culmination of more than a year of 
work by Schmidt; Dione Farria, 
MD, MPH, assistant professor of 
radiology; and Jill Bokern, RN, 
MALLINCKRODT INSTITUTE OF RADIOLOGY 
nurse coordinator of the Breast 
Health Center. They received a 
grant from the St. Louis affiliate of 
the Susan G. Komen Breast Cancer 
Foundation, Inc., to develop the 
educational material. The grant 
also covered production of 1,000 
copies of the booklet and 1,000 
copies of the video, which are 
available through the Alvin J. Site- 
man Cancer Center at Barnes-Jew- 
ish Hospital and Washington 
University School of Medicine. The 
booklet information also is on-line 
at www.barnesjewish.org. 
The breast cancer specialists 
say conversations with patients— 
particularly minority women and 
those with little formal educa- 
tion—convinced them to create the 
material. Many of these women 
locally receive cancer treatment 
through the Breast Health Center 
at Barnes-Jewish Hospital. 
But these educational materi- 
als are appropriate for all women 
who are newly diagnosed with 
breast cancer. As Farria notes 
about other breast cancer books, 
"Some of them, frankly, would be 
overwhelming even for a physician 
who had been recently diagnosed 
with the cancer." 
Schmidt echoes that concern 
and says that hearing a diagnosis of 
cancer causes many women to go 
into shock. "Some of the normal 
cognitive functions just shut 
down," she says. "We wanted to 
emphasize the importance of ask- 
ing questions and of bringing some- 
one along to the doctor 
appointments who can help the 
patient ask questions and remem- 
ber the answers and maybe take 
some notes. Although the 
doctor may explain choices and 
recommendations at length, the 
patient often cannot remember 
what was said because her anxiety 
level is so high." 
Farria started the project 
before she officially came to 
Mallinckrodt Institute in November 
of 1999. After arriving at MIR, she 
collaborated with Schmidt and 
Bokern on gathering ideas (with 
the help of a resource collection 
Bokern had developed) for their 
own undertaking. 
The trio also met one Saturday 
in the spring of 2000 with the 
Breakfast Club, a local support 
group of African-American women 
who have breast cancer. During a 
breakfast meeting in the basement 
of the Centennial Christian Church, 
not far from the Washington Uni- 
versity Medical Center, Deborah 
Price and about a dozen other club 
members shared their experiences 
and the advice they would give 
women. "They just opened up their 
hearts and told us what they felt," 
Bokern said. 
The women spoke about their 
treatment concerns, how family 
members reacted to their situation, 
and other sensitive topics. And 
they emphasized what had helped 
them handle their breast cancer 
diagnosis, such as being patient 
with themselves and turning to 
others for support. f 
Jill Bokern, RN 
FOCAL SPOT, SPRING 2001 
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Sherril Jackson, the club 
president, said African-American 
women frequently have trouble 
accepting that last piece of advice, 
since they often are in charge of 
nurturing others. "It is a difficult 
role for African-American women 
to be the patient. I think it is really 
hard for us to say that we need 
some help." 
In addition, the support group 
emphasized the importance of cele- 
brating life and staying active after 
the diagnosis. Schmidt notes that 
people define an active life in dif- 
ferent ways. "For many of these 
women, it has been involvement 
in a breast cancer support group, 
being active in the community, 
such as the breast cancer commu- 
nity, helping others, or beginning a 
new project." 
The key comments of Break- 
fast Club members shaped the 
topics in the video. Jackson and 
some other club members also 
were among those interviewed 
in the video, which was designed 
and produced—as was the 
booklet—with pro bono assistance 
by staff from Fleishman-Hillard 
Inc., a St. Louis-based communica- 
tions company. 
For the video, the women were 
asked questions and allowed to 
give unrehearsed answers. Medical 
specialists were interviewed using 
this same approach. These special- 
ists included Washington Univer- 
sity School of Medicine's Virginia 
Hermmann, MD, professor of 
endocrine and oncologic surgery, 
and Gerard Doherty, MD, associate 
professor of endocrine and onco- 
logic surgery and director of the 
Breast Surgery Service at the 
Breast Health Center. In addition, 
Lannis Hall-Daniels, MD, a former 
radiation oncology resident at 
Mallinckrodt Institute, and Savan- 
nah Davis, LCSW, a social worker 
at Barnes-Jewish Hospital, partici- 
pated in the video. 
To prepare the educational 
booklet, Schmidt and her col- 
leagues divided up the parts of 
each chapter, focusing on brevity 
and using simple language to con- 
vey what women should know. 
Schmidt worked with the medical 
illustration office (MedPIC) to 
develop illustrations of breast 
cancer concepts, reconstructive 
surgery, and other subjects. 
For example, a dandelion shed- 
ding its seeds was used to illustrate 
cancer's ability to spread. The 
image was borrowed from a previ- 
ous cancer educational program, 
"Learn, Share and Live," developed 
by researchers at Mallinckrodt 
Institute. The team also chose 
some new illustrations, including 
several of female models that they 
hoped minority women would feel 
comfortable viewing. "We really 
wanted women who looked multi- 
cultural, who had typical, middle- 
aged bodies," Schmidt said. "Not 
someone with an idealized body 
shape—like a Barbie doll." 
[Barbut is a registered product of Mattel, Inc.] 
To help ensure the booklet's 
appropriateness, the team called on 
a medical, a surgical, and a radia- 
tion oncologist plus a low-literacy 
specialist to review it. Katherine 
Jahnige, MD, instructor of obstet- 
rics and gynecology and commu- 
nity outreach coordinator for the 
Siteman Cancer Center, oversaw 
an advance showing of the 
"Between Friends" video to a 
breast cancer support group for 
African-American women spon- 
sored by ConnectCare, the regional 
health care safety net for the poor 
and underinsured. 
Schmidt and her colleagues did 
not attend the advance showing for 
fear that the women would be 
reluctant to speak honestly in the 
specialists' presence. Jahnige 
received positive feedback, though, 
and only minor changes were made 
in the video. 
A follow-up review of the edu- 
cational materials began in March. 
Bokern telephoned several dozen 
women who had been diagnosed 
very recently with breast cancer. 
The women, two thirds of whom 
were from minority groups, were 
asked if they would mind receiving 
the video and the booklet by mail 
and responding to a phone ques- 
tionnaire a few weeks later. A 
three-month review of the Web site 
also is scheduled. 
The trio have additional pro- 
jects in the works, including educa- 
tional flip charts that will help 
breast cancer specialists provide 
women with a better understanding 
of what a biopsy, lumpectomy, and 
other treatment options entail. 
Farria notes that the team's 
enthusiasm for that effort is partly 
inspired by the resilient spirit of 
the women who helped create the 
booklet and video. "While some of 
the women were still going through 
issues of continued treatment or a 
tumor recurring, they were work- 
ing actively with the American Can- 
cer Society or helping us with the 
project. They were amazing." EH 
The Breakfast 
Club played an 
important role in the 
production of the 
booklet and video. 
hd* 
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Ill 1998, Ty Bae, MD, PhD, assistant 
professor of radiology, was selected as a 
principal investigator for a Data Coordinating 
and Image Analysis Center in a five-year, 
multicenter study to use magnetic resonance 
imaging (MRI) and ultrasound (US) imaging 
for assessing the progression of autosomal- 
dominant polycystic kidney disease (PKD). 
PKD is a serious renal disorder characterized 
by the development and gradual enlargement 
of cysts in both kidneys. 
The four-year patient recruitment 
process started in January of 2001 and 
already more than 50 patients with PKD have 
agreed to participate in this new effort, called 
the Consortium for Radiologic Imaging Studies 
of PKD—or CRISP. 
Normal kidneys with no disease (left) 
Kidneys showing progression of PKD 
(middle and right) 
PKD: A PROBLEMATIC PROGNOSIS 
The CRISP team is targeting 
the most common genetic kidney 
disorder that affects some 600,000 
people in the United States. PKD 
can cause impaired renal function, 
breathing problems, and bloating. 
When cysts burst, patients also 
may have bleeding, pain, and 
infections. PKD patients are more 
likely to face other serious prob- 
lems as well, such as early-onset 
hypertension, cerebral aneurysms, 
and diverticular disease. As the 
disease progresses, patients may 
develop end-stage renal disease 
(ESRD) and require dialysis or a 
kidney transplant. PKD is the 
fourth-leading cause of kidney fail- 
ure requiring dialysis for survival 
and accounts for five percent of 
the ESRD population in the U.S. The 
cost of PKD-related dialysis therapy 
exceeds $200 million annually. 
Not all patients with PKD 
progress to ESRD. In fact, about 
50 percent of PKD patients will 
have a milder form of the disease, 
with no impairment in renal func- 
tion. Some of the risk factors for 
progression to ESRD have been 
identified, and the genes responsi- 
ble for PKD (PKD-1 and PKD-2 
genes) have been discovered. 
The patients with the PKD-1 
gene, accounting for 85 percent of 
PKD population, tend to have an 
earlier presentation of the disease 
and a worse prognosis. The PKD-2 
patients consist of 10 to 15 percent 
of the population and have a 
milder, late-disease manifestation. 
Other high-risk factors for disease 
progression include males, 
African-Americans, people with 
larger kidneys, and women who 
have had three or more pregnancies. 
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Patients with PKD are usually 
in their 40s or 50s before they go 
to a doctor for diagnosis. And by 
that time, their kidneys are con- 
sumed with cysts. Currently, there 
is no medical therapy to slow or 
stop the progression of this dis- 
ease, but medications currently 
being evaluated in clinical trial 
may change that, says Bae. 
Surgical alternatives also are 
being investigated. Ralph Clay- 
man, MD, a well-known endo- 
scopic surgeon at Washington 
University Medical Center, is eval- 
uating the efficacy of laproscopic 
cystectomy, a minimally invasive 
procedure that reduces cyst bur- 
den. While 50 percent of patients 
with PKD may not require medical 
or surgical treatment, how can 
physicians determine at an early 
stage which patients are destined 
to develop ESRD and do need 
some kind of intervention? 
THE CRISP STUDY 
Currently, the imaging method 
most often used to evaluate these 
patients is ultrasound, an easily 
accessible evaluation tool. But 
ultrasound is not as reliable or as 
accurate as MRI, which provides 
high-resolution, three-dimensional 
images with excellent tissue con- 
trast. However, no large-scale trial 
has ever been done to evaluate the 
accuracy or validity of MRI in 
assessing the progression of PKD. 
"Presently, we cannot predict 
whether a person will be in a high- 
risk group or a low-risk group," 
says Bae. "We can surmise that 
because a patient is male and 
PKD-1, he is at higher risk, but this 
is not enough." 
Bae is a radiologist with 
expertise in body imaging as well 
as image analysis, quantification, 
and processing. However, when he 
first responded to the National 
Institutes of Health request for 
MALLINCKRODT INSTITUTE OF RADIOLOGY 
participation in the PKD study, 
he was a first-year MIR faculty 
member with no experience in 
managing a large, multicenter trial. 
Bae had to convince the NIH that 
he could handle the job. 
Within months, he assembled 
a team of experts at Washington 
University: Saulo Klahr, MD, is a 
prominent nephrologist and editor 
of the journal Kidney Interna- 
tional. Phil Miller, Paul Thompson, 
and Sarah Littlewood, from the 
Division of Biostatistics, have 
extensive experience in web-based 
systems and in coordinating multi- 
center studies. Paul Commean, a 
senior research engineer; Steve 
Moore, a research assistant profes- 
sor; and James Blaine, DSc, direc- 
tor of the Institute's Electronic 
Radiology Laboratory (ERL), pro- 
vide expertise in image transfer. 
Mary Virginia Gaines, an MIR 
research patient coordinator, 
serves as project coordinator. Bae's 
can-do attitude and expertise in 
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image acquisition and analysis 
convinced the NIH to award him 
a $3 million grant. 
The goal of the study, says 
Klahr, is "to conduct a prospective, 
longitudinal trial to evaluate the 
accuracy and validity of MRI in 
determining the progression of 
autosomal-dominant PKD, defined 
as a change in both renal and renal 
cyst volumes over time." In this 
trial, he says, MRI-based measure- 
ments become "the gold standard 
in determining the extent of cystic 
involvement over time." 
Four institutions known for 
PKD research and with existing 
patient databases were brought in 
to recruit and image the study par- 
ticipants: Emory University, Uni- 
versity of Kansas, the Mayo Clinic, 
and University of Alabama. Bae 
then oversaw the development of 
a strong imaging protocol, along 
with a state-of-the-art, web-based 
system for transferring images. 
Mallinckrodt Institute was estab- 
lished as the study's Data Coordi- 
nating and Image Analysis Center 
(DCIAC). The DCIAC would collect 
images from the collaborating 
institutions, segment and analyze 
the images, make the statistical 
analysis, and then properly store 
and record the results using a 
sophisticated data entry system. 
To complement the imaging 
data, each of the clinics is also 
collecting clinical data to correlate 
with the image analyses. Using a 
web-based technology created by 
Phil Miller and the group in Biosta- 
tistics, the clinic coordinators enter 
the data into a database at the 
DCIAC. This data will be used 
to compute statistical correlations 
between clinical, laboratory, and 
genetic parameters and the pro- 
gression of PKD as shown in the 
images sent. From these analyses 
it will be possible to answer ques- 
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pVolycystic 
f kidney disease 
Left: (left to right) 
Paul Koppel, systems 
manager; Jongdae Suh, MD, 
research assistant; 
Barry Brunsden,research 
associate; and Jeong Rim Lee, 
PhD, research associate. 
Right: (left to right) Paul 
Commean, Steve Moore, 
and Jim Blaine of the ERL 
tions about which patients are at 
highest risk of developing ESRD. 
An additional goal is to develop 
cost effective methods to evaluate 
new treatment strategies for PKD. 
It took nearly a year to com- 
plete the final planning and devel- 
opment of the project as 
participants met every six to eight 
weeks at the NIH to discuss their 
progress. Scanning techniques, 
which varied slightly from one 
institution to the other, had to be 
standardized. As a quality control 
measure, four patients were 
recruited to travel from one site 
to another, undergoing scans at 
each site. 
From the outset, the team did 
not want to send patient films by 
surface mail. Instead, they built a 
secure network system, using soft- 
ware developed at Mallinckrodt 
Institute, for transferring these 
images electronically. "Once a 
patient is scanned at any one of 
the four participating institutions, 
the MR and US image data first are 
sent to a dedicated CRISP PC 
workstation at that institution. The 
confidential patient information is 
'scrubbed' from the image headers, 
and the image data are encrypted 
for transmission via the Internet to 
Mallinckrodt Institute for analysis 
and storage," says Bae. 
"Doctor Bae's personal leader- 
ship, approach to problem-solving, 
and medical domain expertise have 
been essential in working with the 
four imaging centers to develop the 
standardized imaging protocols 
required for this study and have 
guided the analysis team in the 
ERL in establishing robust image 
analysis techniques," says Blaine. 
Mallinckrodt Institute will eval- 
uate these images for a number of 
variables: renal volume, cystic vol- 
ume, and the percentage of cystic 
involvement measured by MRI over 
a specific time frame. By following 
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these patients over time, the team 
hopes to determine whether MRI 
effectively assesses the changes in 
renal or cystic volume and whether 
these volume changes correlate with 
functional changes in these patients. 
Bae and his collaborators also want 
to determine which of these factors 
predict disease progression and will 
compare the results of MRI and 
ultrasound studies. 
"We have to prove whether 
the imaging is useful in identifying 
these high-risk patients. If it is, 
how can it be used to guide a 
patient's treatment? Can imaging 
help physicians monitor the 
treatment and the progression 
of disease?" says Bae. 
The next few years will tell the 
story, but the CRISP team is hope- 
ful this research will make a differ- 
ence for PKD patients. "This is a 
very promising area to investigate 
and will contribute to advancing the 
treatment of PKD," adds Bae. Una 
GRAPES, BALLOONS, 
AND IMAGING 
Along the way, Bae admits, there have been 
some small, even humorous, obstacles to the 
study. To test the accuracy and uniformity of the 
measurements taken by all the cooperating institu- 
tions, his team had to build phantoms—models of 
cyst-riddled kidneys—and send them out to the 
study participants. But how to mimic a cyst? First 
Bae tried grapes, which, unlike real cysts, did not 
vary in size and were too quick to spoil, but he 
learned that white grapes simulated cysts better 
than red grapes. Then he tried small balloons. 
"I filled the balloons with water, making 
sure not to introduce any air. Then I tied the bal- 
loons with a very short string," he recalls. "It 
must have taken me an hour to fashion only a 
couple of the balloon cysts, but my wife mastered 
the technique and made around two hundred 
balloons for me." 
That was only the beginning. These balloons 
then had to be placed, very delicately, into a kid- 
ney-shaped mold filled with near-boiling agar 
(a gelatinous colloidal medium). "And once I 
thought the task was done, the balloon would 
suddenly pop," Bae says. "So we had to train the 
balloon, get it used to the hot water, and choose the 
survivor before it was incorporated into the agar." 
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Conventional radiation treat- 
ment of head and neck can- 
cers requires high doses of 
radiation to destroy the tumor tissue, but these 
high levels often are indiscriminately destructive 
to the surrounding normal tissues. These events 
often lead to a number of irreversible side 
effects, including xerostomia (dry mouth) asso- 
ciated with irradiation of the salivary glands. 
Xerostomia can impact a patient's quality of life 
by affecting taste, speech, swallowing, and 
chewing, as well as contributing to dental 
disease, frequent oral infections, and patient 
self-esteem. At Mallinckrodt Institute of Radiol- 
ogy's (MIR) Radiation Oncology Center, recent 
groundbreaking clinical results have proven that 
a novel radiation treatment called intensity 
modulated radiation therapy (IMRT) can greatly 
reduce xerostomia without compromising the 
radiation dose needed to destroy the tumor. 
Heather Stieg, RT(T), a technologist, and Clifford 
Chao, MD, prepare a patient for radiation treatment. 
INITIAL CLINICAL STUDIES 
Head and neck cancers are a 
significant healthcare concern in 
the United States, where approxi- 
mately 55,000 new cases and some 
13,000 deaths are reported annu- 
ally. Treatment of head and neck 
cancers occurs through three 
standard disciplines: surgery, 
chemotherapy, and radiation 
therapy. While chemotherapy and 
surgery can be effective, they are 
invasive and long-term treatment 
regimens that harbor increased 
risks, costs, and side effects. 
Conventional radiation treatments 
are broad-based systems for the 
delivery of radiation to tumors, but 
they often affect the surrounding 
healthy tissue and can lead to sig- 
nificant side effects. Through the 
use of computer-guided systems, 
such as IMRT, radiation therapy 
can be used in a highly selective 
and noninvasive manner to attack 
tumor tissue with minimal effects 
on normal tissues. 
IMRT is an advanced form of 
conformal radiation therapy that 
uses computer algorithms to gener- 
ate complex, three-dimensional 
radiation dose distributions specifi- 
cally tailored to the individual 
tumor volume. And yet the dose 
can be escalated in order to 
destroy the tumor but not affect 
healthy organs, such as the salivary 
glands. With IMRT, radiation is 
administered through a reinforced, 
individually fitted thermoplastic 
mask designed to fit each patient's 
head and neck area. The patient is 
immobilized and lies on the bed of 
a computed tomography scanner 
while the machine acquires imag- 
ing information. Normal and target 
tumor volumes are then delineated 
by physicians, based on clinical 
and radiological findings. Since 
each patient's tumor size or shape, 
as well as facial features, are 
unique, the IMRT process requires 
an incredible level of precision. 
Nevertheless, according to 
Clifford Chao, MD, assistant pro- 
fessor of radiology and principal 
investigator of Mallinckrodt 
Institute's IMRT study," IMRT 
provides the opportunity to control 
the tumor without substantially 
affecting critical normal tissue." 
A number of critical organs are 
located in close proximity to head 
and neck tumors, including the 
spinal cord, brain stem, optic 
systems, and salivary glands. 
"Approximately seventy-five per- 
cent of patients in our study who 
receive conventional radiation 
treatments for head and neck 
cancers exhibit moderate to severe 
dry mouth," says Chao. 
Xerostomia can be qualita- 
tively measured by asking the 
patient questions pertaining to 
associated symptoms such as prob- 
lems with speech, eating, drinking, 
sleeping, or oral and dental health. 






Thermoplastic mask is fitted 
specifically to each patient. 
Xerostomia can also be measured 
quantitatively by directly measur- 
ing the flow of saliva. Nonetheless, 
xerostomia is usually pervasive and 
permanent in most conventionally 
irradiated patients, often leading to 
severe quality of life changes 
including lowered self-esteem. 
According to Chao, the first 
head and neck cancer patients 
treated by IMRT came to the Insti- 
tute in February of 1997. Since then 
an additional 250 patients have 
been treated. "Whereas other insti- 
tutions treat more types of cancer 
with IMRT, the Radiation Oncology 
Center is the leading institution 
in treatment of head and neck 
cancer patients," he says. "We 
have state-of-the-art equipment 
and the best available computer 
planning system." 
In addition to the computers, 
the IMRT treatment protocol 
requires teamwork among physi- 
cians, physicists, dosimetrists, 
consulting surgeons, medical 
oncologists, diagnostic radiolo- 
gists, and nurses. Overall, the 
combined forces of superior 
radiological treatment facilities 
and integrated teamwork make 
the Radiation Oncology Center an 
ideal environment for Chao's 
clinical studies to establish treat- 
ment protocols for head and neck 
cancer patients. 
CLINICAL RESULTS 
Initially, clinical studies were 
performed to determine conformal 
radiation therapy effects on head 
and neck cancer patients through 
forward or inverse planning proto- 
cols. Forward planning is the clas- 
sical or conventional route of 
radiation therapy where the team 
determines all the variables and 
proceeds by a trial-and-error 
method. "Forward planning is a 
very laborious process that 
requires substantial time and effort 
to determine the one combination 
of various directions of radiation 
beams, gantry angles, energy of 
radiation, and type of radiation that 
should be used," says Chao. "And 
the worst part is that even when a 
plan is set up, you cannot be sure 
it is the best one. You do the best 
you can, but you always feel there 
may be a better one that has not 
been explored." 
Inverse planning is the oppo- 
site of forward planning, according 
to Chao, in that the radiation oncol- 
ogist designs the target, defines the 
normal tissues, and estimates the 
amount of radiation to deliver to a 
particular region—and the com- 
puter determines how it will be 
delivered. 
The initial study of IMRT 
involved 17 patients with varying 
types of cancer, using either for- 
ward or inverse planning protocols. 
The results were promising in that 
tumors were controlled by IMRT 
similar to conventional radiation 
treatments. No severe side effects 
were observed with IMRT, and 
parotid gland (major salivary 
gland) damage was reduced. Chao 
indicates that inverse planning pro- 
vided the best, achievable plan 
because tumor and normal tissues 
could be weighed separately. 
In two additional clinical stud- 
ies, Chao was able to support his 
initial findings on tumor control 
and to determine a correlation in 
the amount of saliva produced to 
the dose of radiation delivered to 
the parotid gland. This hypothesis 
was previously controversial 
because other investigators have 
been unable to pinpoint a direct 
correlation. However, through 
computer modeling and quantita- 
tive determinations of saliva flow, 
Chao and his colleagues showed 
that six months after IMRT treat- 
ment, patients exhibited a four per- 
cent drop exponentially in saliva 
flow per Gy (Gy = gray, a standard 
unit of radiation). Additionally, 
Chao demonstrated that a decrease 
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Results o-f Salivary Function 
in saliva flow correlated both quali- 
tatively and quantitatively with the 
symptoms of xerostomia. Overall, 
IMRT effectively targeted head and 
neck tumors while reducing dam- 
age to salivary glands, leading to a 
reduction of xerostomia. 
Following the initial results, 
additional head and neck cancer 
patients were treated by IMRT, and 
the treatment protocol has become 
more efficient and standardized. In 
the initial study IMRT treatment 
took 45 minutes. "Now that we are 
past the learning curve, treatment 
time is down to twenty-five min- 
utes," says Chao. 
"The IMRT treatment tech- 
nique is quite standardized at 
Mallinckrodt Institute's Radiation 
Oncology Center because we set 
criteria based on earlier studies 
and functional outcomes we have 
gathered," adds Chao. 
The goal of the earliest study 
was to set up a treatment protocol 
for patients that allowed the best 
treatment of head and neck tumor 
with parotid sparing or less xeros- 
tomia. However, as with any 
treatment protocol there are 
many variables and there exist 
many different types of cancer 
within the general head and neck 
grouping. According to Chao, the 
planning process was set up so 
those patients with similar diseases 
can be treated with similar proto- 
cols for the sake of consistency. 
FUTURE WORK 
In the future Chao plans to 
build on these studies and create a 
tool for better understanding the 
normal functional changes in the 
major salivary glands, which 
include the parotid, submandibular, 
sublingual, and other minor saliva 
glands. The main goal, according 
to Chao, is to understand the exact 
role of these glands in normal func- 
tion and how each patient's quality 
of life would be affected if the 
glands were damaged. 
Overall, Chao says that MIR's 
Radiation Oncology Center now 
has the proper tools and system to 
treat head and neck cancers and 
will continue to develop the infra- 
structure so that patients receive 
the best treatment possible. "We 
want to know the control rate, 
functional outcome, and quality 
of life effects the IMRT technique 
will have on patients coming to 
the Radiation Oncology Center," 
says Chao. 
The effectiveness of the IMRT 
treatment protocol on head and 
neck cancer patients at the Insti- 
tute has already elicited referrals. 
The majority of patients are from 
the St. Louis region but some 
patients come from Chicago, 
Kansas City, New York, and 
Colorado as well as from other 
countries, such as Israel. Ultimately, 
by way of the superior teamwork 
and modern facilities at MIR, Chao 
hopes that "by using IMRT we can 
improve the cancer cure rate and 
eliminate the high costs associated 
with tumor recurrence." EE! 
IMRT STUDIES 
COINVESTIGATORS 
■ Joseph Deasy, PhD, assistant 
professor of radiology 
■ Joyce Taylor Haynie, RN, MSN 
■ Daniel Low, PhD, assistant 
professor of radiology 
■ Carlos Perez, MD, professor of 
radiology and director of the 
Radiation Oncology Center 
■ James Purdy, PhD, professor of 
radiology and chief of radiation 
physics 
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In this section, the names of employees who are full-time fac- 
ulty or staff or who have an appointment in the Department 
of Radiology are highlighted in boldface type. APPOINTMENTS/ELECTIONS 
PROMOTIONS 
Carmen Dence, MS, 
research instructor in radiol- 
ogy, was promoted to 
research scientist, Division of 
Radiological Sciences. 
Nobuo Horikoshi, MD, 
instructor in radiology, was 
promoted to assistant profes- 
sor of radiology, Radiation 
Oncology Center. 
Eric Klein, MS, assistant 
professor of radiology, was 
promoted to associate pro- 
fessor of radiology, Radiation 
Oncology Center. 
Elizabeth McFarland, MD, 
assistant professor of radiol- 
ogy, was promoted to associ- 
ate professor of radiology, 
Division of Diagnostic 
Radiology. 
Sasa Mutic, MS, instructor 
in radiology, was promoted 
to assistant professor of radi- 
ology, Radiation Oncology 
Center. 
Sandy Runs, MD, instructor 
in radiology, was promoted 
to assistant professor of radi- 
ology, Division of Diagnostic 
Radiology. 
Sally Wagner-Schwarz, 
MS, RPh, research instruc- 
tor in radiology, was pro- 
moted to research scientist, 
Division of Nuclear Medicine. 
Bruce Whiting, PhD, 
instructor in radiology, was 
promoted to research assis- 
tant professor of radiology, 
Division of Radiological 
Sciences. 
Jie Zheng, PhD, instructor 
in radiology, was promoted 
to research assistant profes- 
sor of radiology, Division of 
Radiological Sciences. 
NEW FACULTY 
Samuel Achilefu, PhD, 
associate professor of 
radiology, Division of Radio- 
logical Sciences. 
Zuofeng Li, DSc, assistant 
professor of radiology, 




PhD, assistant professor of 
psychology, was appointed 
research assistant professor 
of radiology, Division of 
Radiological Sciences. 
Carolyn Anderson, PhD, 
associate professor of radiol- 
ogy, was appointed to the 
Editorial Advisory Board of 
the journal Bioconjugate 
Chemistry.    . 
Kyongtae Bae, MD, PhD, 
assistant professor of radiol- 
ogy, was selected for 
membership in the Society of 
Computed Body Tomography 
and Magnetic Resonance. 
Thomas Conturo, MD, PhD, 
associate professor of radiol- 
ogy and adjunct associate 
professor of physics and of 
biomedical engineering, was 
appointed to the National 
Institutes of Health Special 
Study Section SSS-X to review 
neurology grants for medical 
imaging. 
DeWitte Cross, MD, associ- 
ate professor of radiology, 
was appointed to a two-year 
term on the Standards of 
Practice Committee of 
the American Society of 
Interventional & Therapeutic 
Neuroradiology. 
Jay Heiken, MD, professor 
of radiology, chief of abdomi- 
nal radiology, and codirector 
of body computed tomogra- 
phy, was appointed to the 
American College of Radiol- 
ogy's Appropriateness Criteria 
Expert Panel on Gastrointesti- 
nal Imaging. 
Susan Langhorst, PhD, 
CHP, assistant professor of 
radiology, was elected to a 
six-year term on the National 
Council on Radiation Protec- 
tion and Measurements. 
Jeff Michalski, MD, assistant | 
professor of radiology, was 
named chair of the Radiation 
Therapy Oncology Group's 
(RTOG) Image-Guided Radio- 
therapy Committee. 
Scott Mirowitz, MD, profes 
sor of radiology and co- 
director of body magnetic 
resonance imaging, was 
elected to fellowship in the 
American College of Health- 
care Executives. 
Joel Perlmutter, MD, pro- 
fessor of neurology and of 
radiology, was appointed as 
a member of the Scientific 
Advisory Board of the 
American Parkinson Disease 
Association. 
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RANTS  
irolyn Anderson, PhD, 
sociate professor of radi- 
iOgy, as principal investiga- 
tor, received a $50,000 U.S. 
jepartment of Defense 
Brant for research on "Radio- 
labeled matrix metallopro- 
|tt inase inhibitors for breast 
pancer therapy." Coinvesti- 
[ators for the one-year grant 
Ire Jason Lewis, PhD, 
(•( search instructor in radiol- 
D >y, and Wen Ping Li, PhD, 
(research associate. 
fyongtae Bae, MD, PhD, 
ssistant professor of radiol- 
Dgy, and Jack Engsberg, MD, 
Df the Max Biedermann 
nstitute, Switzerland, as 
coprincipal investigators, 
Received a two-year, 
$30,000 foundation grant 
[for research on "Center of 
ravity in scoliosis." 
Clifford Chao, MD, assis- 
nt professor of radiology, 
i principal investigator, 
Received a $510,000 
National Institutes of Health 
rant for his research on 
"Hypoxic image-guided 
ntensity modulated radio- 
therapy." Coinvestigators 
[for the four-year grant are 
Walter Bosch, PhD, 
instructor in radiology; Far- 
rokh Dehdashti, MD, asso- 
j date professor of radiology; 
lark Mintun, MD, profes- 
sor of radiology; Franz 
Pippold, MD, associate 
professor of radiology; 
Samir El-Mofty, MD, Depart- 
nent of Pathology; Bruce 
laughey, MD, Department of 
\ Otolaryngology-Head and 
•leek Surgery; and Kenneth 
Schechtman, PhD, Division 
!
 of Biostatistics. 
GE-AUR 
Fellowship 
In 1999, Katie Vo, MD, 
then a neuroradiology 
fellow, was one of four 
radiology investigators 
nationwide to receive a 
GE-AUR Radiology 
Research Academic 
Fellowship. The two- 
year General Electric- 
Association of University Radiologists fellowships encourage young investigators to 
pursue careers in radiology research. Vo, now an MIR faculty member, is shown at 
the official 2000-2001 stipend presentation with (left to right) Greg Thudium, corpo- 
rate account manager, GE Medical Systems; Gary Brink, director of radiology, 
Barnes-Jewish Hospital; Gilbert Jost, MD, professor and interim director of Mallinck- 
rodt Institute; and Tony Scaduto, regional sales manager, GE Medical Systems. 
Thomas Conturo, MD, 
PhD, associate professor of 
radiology and adjunct asso- 
ciate professor of physics 
and of biomedical engineer- 
ing, as principal investigator, 
received a $2.1 million 
National Institutes of 
Health/National Institute of 
Neurological Disorders and 
Stroke grant for "Tracking 
neuronal fibers in the living 
human brain by MRI." Coin- 
vestigators for the five-year 
grant are Erbil Akbudak, 
PhD, research instructor in 
radiology; Abraham Sny- 
der, PhD, MD, research sci- 
entist of radiology; Joshua 
Shimony, PhD, MD, clinical 
fellow in neuroradiology; 
Harold Burton, PhD, pro- 
fessor of neurology and of 
radiology; Maurizio Cor- 
betta, MD, assistant profes- 
sor of neurology and of 
radiology; Nicolas Lori, 
graduate research assistant 
in radiology; and Gordon 
Shulman, PhD, Department 
of Neurology. Consultants 
are Marcus Raichle, MD, 
professor of radiology and of 
neurology and neurobiology; 
David Van Essen, PhD, 
Department of Anatomy and 
Neurobiology; and William 
Hart, MD, PhD, Department 
of Ophthalmology. 
James Duncan, MD, PhD, 
assistant professor of radiol- 
ogy, received a $25,000 
award from the Cardiovas- 
cular and Interventional 
Radiology Research and 
Education Foundation for 
his project "Hepatic gene 
therapy in neonates." 
Katherine Ponder, PhD, 
Department of Internal Med- 
icine, is coinvestigator. 
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GRANTS 
Continued from page 23 
Eduardo Moros, PhD, 
associate professor of radiol- 
ogy, as principal investiga- 
tor, received a $1 million 
National Institutes of 
Health/National Cancer Insti- 
tute grant for his research on 
"Ultrasonic systems for 
simultaneous thermoradio- 
therapy." Coinvestigators 
for the five-year grant are 
Robert Myerson, PhD, 
MD, professor of radiology; 
William Straube, MS, 
instructor in radiology; and 
Eric Klein, MS, associate 
professor of radiology. 
Pratik Mukherjee, MD, 
clinical fellow in neuroradi- 
ology, as principal investiga- 
tor, received a $50,000 
Berlex/ASNR Fellowship in 
Basic Science Research from 
the American Society of 
Neuroradiology for his pro- 
ject "Comparison of mag- 
netic resonance imaging 
with positron emission 
tomography in the study of 
cerebral hemodynamics." 
Colin Derdeyn, MD, assis- 
tant professor of radiology, 
is Mukherjee's sponsor for 
the one-year grant. 
Joel Perlmutter, MD, pro- 
fessor of neurology and of 
radiology, as principal inves- 
tigator, received a $1.1 mil- 
lion grant from the National 
Institutes of Health/National 
Institute of Neurological 
Disorders and Stroke for 
research on "Mechanisms 
of deep brain stimulation." 
Coinvestigators for the 
three-year grant are 
Jonathan Mink, MD, Depart- 
ment of Neurology; Tom 
Videen, PhD, research pro- 
fessor of neurology and of 
radiology; Tamara Hershey, 
MD, Department of Psychia- 
try; Stephen Moerlein, 
PhD, associate professor 
of radiology; and Lori 
McGee-Minnich, Department 
of Neurology. 
Nikolaos Tsekos, PhD, 
assistant professor of radiol- 
ogy, received a two-year 
grant from the American 
Heart Association in the 
amount of $70,000 for his 
research on "Assessment of 
myocardial sodium and high 
energy phosphates on the 
ischemic and reperfused 
heart with MR techniques." 
He received a three-year, 
$210,00 grant from the 
Whitaker Foundation to 
study "Methods for dynamic 
magnetic resonance imaging 
and spectroscopy of the 
heart." Tsekos received a 
one-year Seed Cycle 1 award 
in the amount of $24,000 
from the Radiological Soci- 
ety of North America for his 
project "Assessment of 
myocardial blood flow with 
magnetization transfer con- 
trast MRI." 
Biello Lecture 
At the Fifteenth Annual Daniel R. Biello 
Memorial Lecture on March 12, Sanjiv Gamb- 
hir, MD, PhD, head of the Bio-Imaging Assay 
Laboratory, Crump Institute for Biological 
Imaging, University of California, Los Angeles, 
spoke on "Advances in molecular imaging for 
imaging gene expression." Barry Siegel, MD, 
(left) professor of radiology and director of 
the Division of Nuclear Medicine, coordinates 













' Carlos Perez, MD, profes- 
sor of radiology and director 
Df the Radiation Oncology 
Center, was named chairper- 
son for the Radiological 
I Protection of Patients in 
Radiation Therapy Session 
for the International Confer- 
ence on the Radiological 
Protection of Patients in 
Diagnostic and Interven- 
tional Radiology, Nuclear 
I Medicine, and Radio- 
lerapy, held March 26-30 
L Malaga, Spain. 
lerold Wallis, MD, associ- 
I ate professor of radiology, 
I was named organizer of the 
Society of Nuclear Medicine 
lidwinter Symposium on 
"Using the Internet for Tele- 
vluclear Medicine" held in 
February in Tampa, Florida. 
Carolyn Anderson, PhD, 
associate professor of radiol- 
ogy, presented "Radiophar- 
maceuticals for cancer 
imaging and therapy" at Cen- 
tral Missouri State Univer- 
sity, Warrensburg, Missouri, 
February 8. 
Kyongtae Bae, MD, PhD, 
assistant professor of radiol- 
ogy, spoke on "The evolving 
role of MRCP in pancreato- 
biliary disease" at A Galaxy 
of Gastroenterology, spon- 
sored by Washington Univer- 
sity School of Medicine's 
Continuing Medical Educa- 
tion office, St. Louis, 
Missouri, March 9. 
Thomas Conturo, MD, 
PhD, associate professor of 
radiology and adjunct associ- 
ate professor of physics and 
of biomedical engineering, 
as invited speaker, presented 
"White matter fiber tractog- 
raphy" at the National Insti- 
tutes of Health Diffusion 
Tensor MRI (DT-MRI) Con- 
ference: From Bench to Bed- 
side, Bethesda, Maryland, 
December 6 and 7. He spoke 
on "Functional magnetic res- 
onance imaging for neuro- 
science research" at the MR 
Imaging and Spectroscopy 
Center, Louisville, Kentucky, 
January 11 and 12. 
Maurizio Corbetta, MD, 
assistant professor of neurol- 
ogy and of radiology, pre- 
sented "Mapping of visual 
systems in the human brain" 
at the European School of 
Functional Magnetic Reso- 
nance Imaging, Utrech, Hol- 
land, January 13. He spoke 
on "Attentional networks or 
attentional tricks" at the 
International Neuropsycho- 
logical Society meeting, 
Chicago, Illinois, February 17. 
DeWitte Cross, MD, asso- 
ciate professor of radiology, 
spoke on "CNS thromboly- 
sis" at the South Carolina 
Upstate Neurovascular Sym- 
posium, Greenville, South 
Carolina, March 17. 
Colin Derdeyn, MD, assis- 
tant professor of radiology, 
presented "Late thromboem- 
bolic events after treatment 
of intracranial aneurysms 
with GDC" at the American 
Heart Association Annual 
Stroke Meeting, Fort Laud- 
erdale, Florida, February 16. 
Perry Grigsby, MD, MBA, 
professor of radiology, 
spoke on "Radiotherapy for 
stage IB carcinoma of the 
cervix" at the 9th Annual 
Conference of the Associa- 
tion of Gynaecologic Oncolo- 
gists of India, Gwalior, India, 
December 1-3. 
Jay Heiken, MD, professor 
of radiology, chief of abdom- 
inal radiology, and codirec- 
tor of body computed 
tomography, presented 
"Characterization of liver 
tumors with CT and MRI: 
Part 1—benign lesions;" 
"Characterization of liver 
tumors with CT and MRI: 
Part 2—malignant lesions;" 
and "Pancreatic carcinoma: 
detection and staging with 
CT" at the Annual Course of 
Radiology, The Mexican 
Society of Radiology and 
Imaging, Mexico City, Mex- 
ico, February 1-5. He spoke 
on "Hepatic masses: charac- 
terization with CT and MRI;" 
"Imaging evaluation of renal 
masses;" "Helical CT of the 
urinary tract;" "Imaging of 
nontraumatic emergencies 
of the gastrointestinal tract;" 
and "CT colonography: state 
of the art" at Advances in 
Imaging: 2001, sponsored 
by Louisiana State University 
and Tulane University 
Health Science Centers, 
Breckenridge, Colorado, 
February 18-23. 
Anil Khosla, MD, instructor 
in radiology, spoke on 
"Intracranial manifestations 
of systemic cancer—imaging 
issues" and "Diffusion imag- 
ing in neurological diagno- 
sis" at the All India Institute 
of Medical Sciences, New 
Delhi, India, March 20. 
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Eric Klein, MS, associate 
professor of radiology, pre- 
sented "The conformal and 
intensity modulated therapy 
programs at Mallinckrodt 
Institute" and "Physics 
issues with DMLC delivery" 
at the University of Michi- 
gan, Ann Arbor, Michigan, 
March 15. 
Jason Lewis, PhD, research 
instructor in radiology, pre- 
sented "Cu-64-bis(thiosemi- 
carbazone) complexes as 
agents for diagnosis and 
radiotherapy" at the 2000 
International Chemical 
Congress of Pacific Basin 
Societies, Honolulu, Hawaii, 
December 18. 
RSNA honors 
Elizabeth McFarland, MD, 
associate professor of radiol- 
ogy, spoke on "Dimensional 
CT angiography of endovas- 
cular aortic stent grafts" 
at the Midwest Regional Non- 
invasive Vascular Society, St. 
Louis, Missouri, February 15. 
Robert McKinstry, MD, 
PhD, assistant professor of 
radiology, presented "Web 
resources for physicians," 
"Web resources for con- 
sumers," "Solutions for 
enhancing your practice," 
and "Authentication and 
Internet security" at the 
American Medical Associa- 
tion (AMA) House of Dele- 
At the 86'" Annual Scientific Meeting of the Radiologi- 
cal Society of North America, held in Chicago, Illinois, 
November 26 through December 1, 2000, Anil 
Khosla, MD, instructor in radiology, was a multiple 
winner of the Case of the Day: Sunday for cardiac, 
nuclear medicine, and ultrasound; Monday for cardiac 
and neuroradiology. Medhi Poustchi-Amin, MD, 
clinical fellow in magnetic resonance imaging, 
received a Certificate of Merit for the scientific 
exhibit "Practical cardiac MRI." 
gates Interim Meeting, Inter- 
net Health Roadshow, 
Orlando, Florida, December 
4. He spoke on "Novice Inter- 
net training," "Introduction to 
Internet solutions," "Using 
Internet applications," and 
"Creating Web sites" at the 
AMA Internet Health Road- 
show, Jackson, Mississippi, 
February 27, and at the AMA 
National Leadership Develop- 
ment Conference Internet 
Health Roadshow, Washing- 
ton, DC, March 3 and 4. 
Jeff Michalski, MD, assis- 
tant professor of radiology, 
spoke on "Techniques and 
management of patients 
receiving prostate 
brachytherapy" and 
"Advances in radiation ther- 
apy of prostate cancer" at 
the University of Louisville 
Hospital, Louisville, Ken- 
tucky, December 5 and 6. He 
presented "3D conformal 
radiation therapy and tradi- 
tional therapy" at the Radia- 
tion Therapy Oncology 
Group/Patient Advocacy 
Committee Meeting, Tampa, 
Florida, February 9. He pre- 
sented "Debate: IMRT only 
for major referral centers" to 
the American Society of 
Therapeutic Radiation 
Oncologists, Chicago, Illi- 
nois, March 9. Michalski 
spoke on "The role of hor- 
monal therapy in the treat- 
ment of prostate cancer" at 
the AstraZeneca Speaker's 
Bureau/Illinois Oncology 
Nurses Society meeting, 
Springfield, Illinois, March 
14. He presented "Innova- 
tions in radiation therapy for 
prostate cancer" at Inova 
Fairfax Hospital, Falls 
Church, Virginia, March 29. 
Mark Mintun, MD, profes- 
sor of radiology, as invited 
lecturer, spoke on "Brain 
mapping with PET and 
SPECT" at the 39th Annual 
Meeting of the American Col- 
lege of Neuropsychopharma- 
cology, San Juan, Puerto Rico, 
December 10. 
Stephen Moerlein, PhD, 
associate professor of radiol- 
ogy, presented "Preparation 
of flumazenil Cll injection 
for PET measurement of 
benzodiazepine receptor 
activity" at the 148th Annual 
Meeting of the American 
Pharmaceutical Association 
San Francisco, California, 
March 16-20. 
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Carlos Perez, MD, professor 
of radiology and director of 
the Radiation Oncology Cen- 
ter, spoke on "Preoperative 
short duration radiation ther- 
apy versus conventional radi- 
ation for rectal cancer;" 
"Permanent implants in 
prostate cancer: indications, 
contraindications, and 
results;" "Cancer of the 
tongue and mouth floor: 
When radiation therapy is 
indicated;" "Cancer of the 
ongue and mouth floor: 
hemoirradiation;" "Cancer of 
e tongue and mouth floor: 
anagement of radiation toxi- 
city;" and "Complications 
•elated to the use of radiation 
.erapy" at XV Congresso 
Brasileiro de Cancerologia, 
Salvador, Bahia, Brazil, 
ovember 26-30. He spoke on 
"Place of radiation therapy in 
the management of breast 
cancer," "Radiation therapy 
echniques in the manage- 
ent of breast cancer," and 
Multimodality treatment of 
locally advanced breast can- 
leer" at the 4"1 United Arab 
narrates International Can- 
cer Conference, Abu Dhabi, 
nited Arab Emirates, Janu- 
28-31. He presented "Eco- 
omics of different treatment 
ptions in prostate" at the 
ucletron's High-Dose Rate 
onotherapy Brachytherapy 
eeting, San Francisco, Cali- 
brnia, February 16. He pre- 
ented "The role of radiation 
erapy in modern clinical 
neology" at the Hadrother- 
py Conference, Trento, Italy, 
ebruary22. Perez spoke on 
Metastatic bone pain" at the 
Thomas Jefferson Hospital, 
Philadelphia, Pennsylvania, 
March 21, and at the Depart- 
ment of Radiation Oncology, 
Erie Regional Cancer Center, 
Erie, Pennsylvania, April 10. 
Joel Perlmutter, MD, pro- 
fessor of neurology and of 
radiology, spoke on "Altered 
cortical blood flow response 
to L-dopa in chronically 
L-dopa treated Parkinson's 
disease" and "Blood flow 
responses to deep brain stim- 
ulation of the thalamus in 
essential tremor" at the 7"' 
International Meeting of The 
Basal Ganglia Society, Bay 
of Islands, New Zealand, Feb- 
ruary 12. 
Senturia Lecture 
On February 12, James Thrall, MD, professor and chairman, Department of Radi- 
ology, Massachusetts General Hospital, presented the Seventh Annual Hyman R. 
Senturia Lecture, "Managing change in twenty-first century radiology practice." 
Shown with Thrall (right) is Scott Mirowitz, MD, professor of radiology and 
coordinator of the Senturia Lecture. 
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Mehdl Poustchi-Amin, MD, 
clinical fellow in magnetic 
resonance imaging, presented 
"MRI of the knee: normal vari- 
ants, diagnostic pitfalls, and 
artifacts;" "MRI of the shoul- 
der: normal variants, diagnos- 
tic pitfalls, and artifacts;" and 
"Practical cardiac MRI: princi- 
ples and applications. A 
review for the general radiolo- 
gist" at the American Roent- 
gen Ray Society Annual 
Meeting, Seattle, Washington, 
April 29-May 4. 
Stuart Sagel, MD, professor 
of radiology, chief of chest 
radiology, and codirector of 
body computed tomography, 
spoke on "CT angiography for 
pulmonary embolism," "CT of 
the pleura," "CT of non-vascu- 
lar mediastinal masses," and 
"Role of CT in bronchogenic 
carcinoma" at the 171" Annual 
Computed Body Tomography 
Course: The Cutting Edge, 
Orlando, Florida, February 
15-18. As visiting professor, 
he presented "CT angiogra- 
phy for pulmonary 
embolism,"" CT of the tho- 
rax: anatomic variants and 
pitfalls," and "Role of CT in 
bronchogenic carcinoma" to 
the Department of Radiology, 
University of California, San 
Diego, March 5 and 6. 
Vijay Sharma, PhD, assis- 
tant professor of radiology, 
presented "Novel gallium(ni) 
complexes as potential PET 
imaging agents for probing 
multidrug resistance (MDR1) 
P-glycoprotein (Pgp): effect of 
MDR reversal agents" at the 
American Chemistry Society 
Pacifichem 2000 Meeting, 
Honolulu, Hawaii, December 
14-19. 
Barry Siegel, MD, professor 
of radiology and of medicine, 
and director of the Division of 
Nuclear Medicine, presented 
"Applications of PET in 
oncology" at Mount Sinai 
Medical Center and at Baptist 
Medical Center, Miami Beach, 
Florida, February 2. 
Marilyn Siegel, MD, profes- 
sor of radiology and of pedi- 
atrics, spoke on "The 
differential diagnosis and 
postnatal management of pre- 
natally detected pyelectasis," 
"Intracranial hemorrhage in 
the neonate and infant," and 
"The acute pediatric 
abdomen" at the British Med- 
ical Ultrasound Society, East- 
bourne, United Kingdom, 
December 5-7. As visiting 
professor, she presented 
"MR/CT of common pediatric 
abdominal tumors" and 
"Ultrasonography of the acute 
pediatric abdomen" at Yale 
University, New Haven, Con- 
necticut, March 1. Siegel 
spoke on "Ultrasonography of 
intracranial hemorrhage and 
ischemia" and "Sonography of 
acute right lower quadrant 
pain in children" at the 45th 
Annual Convention of the 
American Institute of Ultra- 
sound in Medicine, Orlando, 
Florida, March 11 and 12. 
Jerold Wallis, MD, associ- 
ate professor of radiology, 
presented "Third party tools 
for tele-nuclear medicine" at 
the Society of Nuclear Medi- 
cine Midwinter Symposium, 
Tampa, Florida, February 10. 
Todd Wasserman, MD, pro- 
fessor of radiology, presented 
"Long-term toxicity of radia- 
tion therapy for Hodgkin's 
disease" at the Rabin Medical 
Center, Tel Aviv University, 
Petach Tikva, Israel, Decem- 
ber 15. He presented "Protec- 
tors" to the Cancer Education 
Program-Tumor Board, 
Elkhart General Healthcare 
System, Elkhart, Indiana, 
December 20, and at the 
Lakeland Continuing Medical 
Education Center, St. Joseph, 
Michigan, March 22. Wasser- 
man spoke on "Radioprotec- 
tion in oncology" at Grand 
Rounds, Northwestern Memo- 
rial Hospital/Northwestern 
University Cancer Center, 
Chicago, Illinois, January 19. 
SYMPOSIUM 
In this section ofFYI, only 
those faculty and staff who 
have MIR appointments are 
listed. 




Twenty-fourth Annual Course | 
South Beach, Florida 
March 19-23, 2001 
Stuart Sagel, MD, Interac- 
tive Case Session: Chest. 
WORKSHOP I 
Stuart Sagel, MD, "CT of 
the thorax: anatomic vari- 
ants and pitfalls." 
WORKSHOP II 
Jay Heiken, MD, "Liver 
lesion characterization." 
WORKSHOP III 
Stuart Sagel, MD, "CT of 
the thorax: anatomic vari- 
ants and pitfalls." 
Marilyn Siegel, MD, "Pedi 
atric imaging: techniques 
and oncology." 
2ND SUB: WORKSHOP IV 
Stuart Sagel, MD, "CT of 
mediastinal masses." 
Marilyn Siegel, MD, "MRI 
of musculoskeletal masses.' 
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(Left to right) Douglas Curry, MD; 
Sailendra Naidu, MD; and 
James Goddard, MD. 
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